|
Insider Trading: Momenta Pharmaceuticals Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Momenta Pharmaceuticals Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Momenta Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Momenta Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is MNTA.
The reporting company's CIK number is 1235010.
The total value of stock buying since 2005 is $0.
The total value of stock sales is $31,088,565.
The total value of stock exercises is $283,949.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Momenta Pharmaceuticals Inc (MNTA) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Figure 2. Average prices of insider buys, sales, and option exercises at Momenta Pharmaceuticals Inc (MNTA) in the past 24 months. See table 2 for insider transaction details.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Momenta Pharmaceuticals Inc (MNTA).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-11 | 0 | 0 | 371 | 2,882 | 0 | 0 |
| 2008-08 | 0 | 0 | 48,540 | 849,716 | 0 | 0 |
| 2008-06 | 0 | 0 | 335 | 4,440 | 0 | 0 |
| 2008-04 | 0 | 0 | 9,375 | 121,875 | 0 | 0 |
| 2008-03 | 0 | 0 | 375 | 3,449 | 0 | 0 |
| 2007-12 | 0 | 0 | 1,500 | 10,770 | 0 | 0 |
| 2007-10 | 0 | 0 | 10,000 | 125,972 | 0 | 0 |
| 2007-09 | 0 | 0 | 10,000 | 111,750 | 0 | 0 |
| 2007-08 | 0 | 0 | 10,000 | 105,053 | 0 | 0 |
| 2007-07 | 0 | 0 | 10,000 | 104,400 | 0 | 0 |
| 2007-06 | 0 | 0 | 10,000 | 121,250 | 0 | 0 |
| 2007-05 | 0 | 0 | 10,000 | 120,666 | 0 | 0 |
| 2007-04 | 0 | 0 | 16,666 | 246,290 | 0 | 0 |
| 2007-03 | 0 | 0 | 10,000 | 123,375 | 0 | 0 |
| 2007-02 | 0 | 0 | 21,250 | 376,800 | 11,250 | 94,612 |
| 2007-01 | 0 | 0 | 93,666 | 1,587,763 | 0 | 0 |
| 2006-12 | 0 | 0 | 136,166 | 2,299,866 | 0 | 0 |
| 2006-11 | 0 | 0 | 142,166 | 2,276,962 | 0 | 0 |
| 2006-10 | 0 | 0 | 86,254 | 1,287,393 | 0 | 0 |
| 2006-09 | 0 | 0 | 258,976 | 3,931,214 | 0 | 0 |
| 2006-08 | 0 | 0 | 370,088 | 6,015,120 | 0 | 0 |
| 2006-07 | 0 | 0 | 21,500 | 274,577 | 1,500 | 12,150 |
| 2006-06 | 0 | 0 | 10,000 | 139,400 | 0 | 0 |
| 2006-05 | 0 | 0 | 45,821 | 706,560 | 0 | 0 |
| 2006-04 | 0 | 0 | 165,700 | 2,811,563 | 0 | 0 |
| 2006-03 | 0 | 0 | 3,383 | 82,545 | 0 | 0 |
| 2006-02 | 0 | 0 | 81,706 | 2,000,728 | 21,875 | 177,187 |
| 2005-12 | 0 | 0 | 22,000 | 536,926 | 0 | 0 |
| 2005-11 | 0 | 0 | 22,000 | 463,900 | 0 | 0 |
| 2005-10 | 0 | 0 | 22,000 | 590,448 | 0 | 0 |
| 2005-09 | 0 | 0 | 22,200 | 596,728 | 0 | 0 |
| 2005-08 | 0 | 0 | 22,000 | 509,780 | 0 | 0 |
| 2005-07 | 0 | 0 | 22,000 | 491,596 | 0 | 0 |
| 2005-06 | 0 | 0 | 89,500 | 1,213,204 | 0 | 0 |
| 2005-05 | 0 | 0 | 90,500 | 843,604 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Momenta Pharmaceuticals Inc (MNTA)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-11-19 | Shea Richard P (SVP, CFO) | Sale | 371 | 7.77 | 2,882 |
| 2008-08-16 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 40 | 12.91 | 516 |
| 2008-08-08 | Langer Robert | Sale | 20,000 | 16.81 | 336,200 |
| 2008-08-06 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 28,500 | 18.00 | 513,000 |
| 2008-06-16 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 335 | 13.26 | 4,440 |
| 2008-04-24 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 9,375 | 13.00 | 121,875 |
| 2008-03-17 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 375 | 9.20 | 3,449 |
| 2007-12-17 | Bishop John E (Senior VP, Pharmaceutical Scie) | Sale | 1,500 | 7.18 | 10,770 |
| 2007-10-16 | Sasisekharan Ram | Sale | 4,605 | 12.40 | 57,078 |
| 2007-10-15 | Sasisekharan Ram | Sale | 5,395 | 12.77 | 68,894 |
| 2007-09-17 | Sasisekharan Ram | Sale | 10,000 | 11.18 | 111,750 |
| 2007-08-15 | Sasisekharan Ram | Sale | 10,000 | 10.51 | 105,053 |
| 2007-07-16 | Sasisekharan Ram | Sale | 10,000 | 10.44 | 104,400 |
| 2007-06-15 | Sasisekharan Ram | Sale | 10,000 | 12.12 | 121,250 |
| 2007-05-15 | Sasisekharan Ram | Sale | 10,000 | 12.07 | 120,666 |
| 2007-04-17 | Whoriskey Susan K (V.P., Lic. & Bus. Dev.) | Sale | 6,666 | 14.91 | 99,390 |
| 2007-04-16 | Sasisekharan Ram | Sale | 10,000 | 14.69 | 146,900 |
| 2007-03-15 | Sasisekharan Ram | Sale | 10,000 | 12.34 | 123,375 |
| 2007-02-15 | Sasisekharan Ram | Sale | 10,000 | 14.06 | 140,550 |
| 2007-02-08 | Lisa Carron Shmerling (V.P., Legal Affairs) | Sale | 11,250 | 21.00 | 236,250 |
| 2007-02-08 | Lisa Carron Shmerling (V.P., Legal Affairs) | Option Exercise | 11,250 | 8.41 | 94,612 |
| 2007-01-17 | Shapiro Bennett M | Sale | 18,000 | 16.17 | 291,037 |
| 2007-01-16 | Whoriskey Susan K (V.P., Lic. & Bus. Dev.) | Sale | 6,666 | 16.95 | 112,988 |
| 2007-01-16 | Sasisekharan Ram | Sale | 10,000 | 17.64 | 176,420 |
| 2007-01-10 | Crane Alan L | Sale | 50,000 | 17.45 | 872,318 |
| 2006-12-19 | Whoriskey Susan K (V.P., Lic. & Bus. Dev.) | Sale | 6,666 | 15.92 | 106,122 |
| 2006-12-18 | Shapiro Bennett M | Sale | 9,000 | 16.77 | 150,959 |
| 2006-12-18 | Crane Alan L | Sale | 62,500 | 16.42 | 1,026,541 |
| 2006-12-15 | Sasisekharan Ram | Sale | 8,000 | 16.92 | 135,392 |
| 2006-12-08 | Crane Alan L | Sale | 50,000 | 17.62 | 880,852 |
| 2006-11-21 | Whoriskey Susan K (V.P., Lic. & Bus. Dev.) | Sale | 6,666 | 17.46 | 116,388 |
| 2006-11-16 | Shapiro Bennett M | Sale | 9,000 | 16.68 | 150,075 |
| 2006-11-16 | Crane Alan L | Sale | 62,500 | 16.37 | 1,023,295 |
| 2006-11-15 | Sasisekharan Ram | Sale | 12,000 | 16.41 | 194,252 |
| 2006-11-08 | Crane Alan L | Sale | 50,000 | 15.19 | 759,452 |
| 2006-10-18 | Shapiro Bennett M | Sale | 9,000 | 15.24 | 137,115 |
| 2006-10-17 | Whoriskey Susan K (V.P., Lic. & Bus. Dev.) | Sale | 6,666 | 15.66 | 104,389 |
| 2006-10-16 | Sasisekharan Ram | Sale | 10,000 | 15.50 | 154,006 |
| 2006-10-13 | Crane Alan L | Sale | 14,932 | 15.00 | 223,980 |
| 2006-10-12 | Crane Alan L | Sale | 15,300 | 15.00 | 229,500 |
| 2006-10-11 | Crane Alan L | Sale | 10,200 | 15.00 | 153,000 |
| 2006-10-10 | Crane Alan L | Sale | 9,856 | 15.00 | 147,840 |
| 2006-10-03 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 10,000 | 13.29 | 132,883 |
| 2006-09-20 | Shapiro Bennett M | Sale | 9,000 | 15.00 | 135,000 |
| 2006-09-19 | Whoriskey Susan K (V.P., Lic. & Bus. Dev.) | Sale | 6,666 | 15.03 | 100,189 |
| 2006-09-15 | Sasisekharan Ram | Sale | 10,000 | 15.20 | 152,000 |
| 2006-09-13 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 33,950 | 15.18 | 515,332 |
| 2006-09-12 | Crane Alan L (C.E.O.) | Sale | 38,174 | 15.00 | 572,610 |
| 2006-09-12 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 49,771 | 15.03 | 748,157 |
| 2006-09-11 | Crane Alan L (C.E.O.) | Sale | 50,000 | 15.05 | 752,500 |
| 2006-09-11 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 16,279 | 15.05 | 245,026 |
| 2006-09-07 | Crane Alan L (C.E.O.) | Sale | 12,402 | 15.35 | 190,370 |
| 2006-09-06 | Reeders Stephen T (Director) | Sale | 1,134 | 15.26 | 17,304 |
| 2006-09-05 | Crane Alan L (C.E.O.) | Sale | 21,600 | 15.90 | 343,386 |
| 2006-09-01 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 10,000 | 15.93 | 159,340 |
| 2006-08-31 | Crane Alan L (President, C.E.O.) | Sale | 33,000 | 16.47 | 543,400 |
| 2006-08-30 | Crane Alan L (President, C.E.O.) | Sale | 50,000 | 16.41 | 820,700 |
| 2006-08-30 | Reeders Stephen T (Director) | Sale | 27,005 | 16.53 | 446,392 |
| 2006-08-29 | Reeders Stephen T (Director) | Sale | 165,280 | 16.50 | 2,727,120 |
| 2006-08-25 | Reeders Stephen T (Director) | Sale | 15,803 | 16.50 | 260,749 |
| 2006-08-18 | Shapiro Bennett M | Sale | 9,000 | 15.07 | 135,623 |
| 2006-08-15 | Sasisekharan Ram | Sale | 10,000 | 13.96 | 139,645 |
| 2006-08-09 | Crane Alan L (President, C.E.O.) | Sale | 29,700 | 15.21 | 451,625 |
| 2006-08-08 | Crane Alan L (President, C.E.O.) | Sale | 20,300 | 15.74 | 319,420 |
| 2006-08-03 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 2,500 | 16.93 | 42,325 |
| 2006-08-02 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 5,000 | 17.10 | 85,516 |
| 2006-08-01 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 2,500 | 17.04 | 42,605 |
| 2006-07-25 | Bishop John E (VP Pharma Sciences & Manufact) | Sale | 1,500 | 20.00 | 30,000 |
| 2006-07-25 | Bishop John E (VP Pharma Sciences & Manufact) | Option Exercise | 1,500 | 8.10 | 12,150 |
| 2006-07-17 | Sasisekharan Ram | Sale | 10,000 | 11.71 | 117,059 |
| 2006-07-06 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 10,000 | 12.75 | 127,518 |
| 2006-06-05 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 4,000 | 13.70 | 54,800 |
| 2006-06-01 | Venkataraman Ganesh (Senior V.P., Research) | Sale | 6,000 | 14.10 | 84,600 |
| 2006-05-16 | Whoriskey Susan K (V.P., Lic. & Bus. Dev.) | Sale | 5,821 | 14.50 | 84,404 |
| 2006-05-15 | Sasisekharan Ram | Sale | 10,000 | 14.54 | 145,414 |
| 2006-05-03 | Venkataraman Ganesh (Senior VP, Research) | Sale | 30,000 | 15.89 | 476,742 |
| 2006-04-21 | Sasisekharan Ram | Sale | 88,600 | 17.08 | 1,513,480 |
| 2006-04-20 | Sasisekharan Ram | Sale | 77,100 | 16.84 | 1,298,083 |
| 2006-03-02 | Reeders Stephen T (Director) | Sale | 3,383 | 24.40 | 82,545 |
| 2006-02-27 | Reeders Stephen T (Director) | Sale | 29,861 | 24.35 | 727,115 |
| 2006-02-17 | Bishop John E (VP Pharma Sciences & Manufact) | Sale | 21,875 | 24.58 | 537,700 |
| 2006-02-17 | Bishop John E (VP Pharma Sciences & Manufact) | Option Exercise | 21,875 | 8.10 | 177,187 |
| 2006-02-17 | Brugger Stephen B (Senior Vice President) | Sale | 29,970 | 24.56 | 735,913 |
| 2005-12-15 | Sasisekharan Ram | Sale | 16,000 | 25.31 | 404,992 |
| 2005-12-01 | Venkataraman Ganesh (Senior VP, Research) | Sale | 6,000 | 21.99 | 131,934 |
| 2005-11-15 | Sasisekharan Ram | Sale | 16,000 | 20.90 | 334,336 |
| 2005-11-01 | Venkataraman Ganesh (Senior VP, Research) | Sale | 6,000 | 21.59 | 129,564 |
| 2005-10-17 | Sasisekharan Ram | Sale | 16,000 | 26.11 | 417,792 |
| 2005-10-03 | Venkataraman Ganesh (Senior VP, Research) | Sale | 6,000 | 28.78 | 172,656 |
| 2005-09-15 | Sasisekharan Ram | Sale | 16,000 | 27.70 | 439,270 |
| 2005-09-01 | Venkataraman Ganesh (Senior VP, Research) | Sale | 6,000 | 25.31 | 151,866 |
| 2005-08-15 | Sasisekharan Ram | Sale | 16,000 | 22.34 | 357,440 |
| 2005-08-01 | Venkataraman Ganesh (Senior VP, Research) | Sale | 6,000 | 25.39 | 152,340 |
| 2005-07-15 | Sasisekharan Ram | Sale | 16,000 | 23.37 | 373,936 |
| 2005-07-01 | Venkataraman Ganesh (Senior VP, Research) | Sale | 6,000 | 19.61 | 117,660 |
| 2005-06-23 | Sasisekharan Ram | Sale | 19,000 | 20.65 | 392,350 |
| 2005-06-16 | Venkataraman Ganesh (Senior VP, Research) | Sale | 10,500 | 17.00 | 178,500 |
| 2005-06-16 | Sasisekharan Ram | Sale | 54,000 | 10.62 | 573,210 |
| 2005-06-01 | Venkataraman Ganesh (Senior VP, Research) | Sale | 6,000 | 11.52 | 69,144 |
| 2005-05-26 | Venkataraman Ganesh (Senior VP, Research) | Sale | 10,000 | 11.00 | 110,000 |
| 2005-05-23 | Sasisekharan Ram | Sale | 19,000 | 10.00 | 190,095 |
| 2005-05-16 | Sasisekharan Ram | Sale | 16,000 | 9.39 | 150,192 |
| 2005-05-09 | Venkataraman Ganesh (Senior VP, Research) | Sale | 10,500 | 9.54 | 100,222 |
| 2005-05-06 | Sasisekharan Ram | Sale | 19,000 | 8.63 | 164,008 |
| 2005-05-04 | Venkataraman Ganesh (Senior VP, Research) | Sale | 9,600 | 8.28 | 79,507 |
| 2005-05-03 | Venkataraman Ganesh (Senior VP, Research) | Sale | 6,400 | 7.75 | 49,580 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Momenta Pharmaceuticals Inc (symbol MNTA,
CIK number 1235010) see
the Securities and Exchange Commission (SEC) website.
|
|
